ArticleResearch square2026
Alpha Reactivity Dynamics Reveal Multi-System Variability Without Global Alpha Slowing in Fragile X Syndrome.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Fragile X syndrome (FXS) is associated with alterations in alpha-band activity recorded using electroencephalography (EEG), including reports of alpha slowing, that may reflect impaired inhibitory regulation and network-level dysfunction. However, it remains unclear whether these abnormalities represent a global shift in oscillatory frequency or dissociable disruptions across distinct systems. In the present study, we leveraged alpha reactivity dynamics, defined as eyes-open to eyes-closed modulation, to probe alpha function in 23 individuals with FXS and 23 typically developing controls using both absolute and relative spectral measures. In FXS, absolute alpha reactivity showed a robust, region-specific reduction localized to occipital cortex, consistent with impaired sensory-inhibitory modulation. While relative alpha reactivity revealed more widespread attenuation across regions, indicating broader network alterations. Peak reactivity frequency showed no evidence of global slowing but was consistent with localized shifts toward lower frequencies. These effects were region- and sex-specific, with females showing reduced frontal relative peak frequency and males showing associations between lower relative peak frequency in non-occipital regions and higher IQ. These findings support a multi-system model of alpha dysfunction in FXS, characterized by posterior inhibitory deficits and distributed network alterations, and highlight alpha reactivity dynamics as a promising translational biomarker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.